79 filings
Page 3 of 4
DEFA14A
hpxr4s2 mn
28 Apr 22
Additional proxy soliciting materials
8:32am
DEF 14A
zc2hq0
28 Apr 22
Definitive proxy
8:30am
8-K
to60w vxqbv298
14 Apr 22
Departure of Directors or Certain Officers
4:01pm
EFFECT
ouobglj
21 Mar 22
Notice of effectiveness
12:15am
CORRESP
7zeevkdt2badg530zit
16 Mar 22
Correspondence with SEC
12:00am
UPLOAD
wpd4q
16 Mar 22
Letter from SEC
12:00am
S-3
8z9ju7 colhj2uyka
14 Mar 22
Shelf registration
5:15pm
S-8
dox t6lu3
14 Mar 22
Registration of securities for employees
5:12pm
8-K
mcq7zhcmxtn3v6je
17 Jun 21
Entry into a Material Definitive Agreement
8:13am
10-Q
i920a ua7s1h1h0jm1o
6 May 21
Quarterly report
4:02pm
10-K
qktow8hk2625qk4kpw0
25 Mar 21
Annual report
4:01pm
S-8
8gl41r zy65
9 Feb 21
Registration of securities for employees
5:12pm
8-K
34jboz1t
9 Feb 21
Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to
4:21pm
424B4
mpjnn058szqcks 7b
8 Feb 21
Prospectus supplement with pricing info
6:07am
S-1MEF
svci n5gumpyyuse
5 Feb 21
Registration of additional securities for an S-1
6:06am
EFFECT
hko8g2tsa5j
5 Feb 21
Notice of effectiveness
12:15am
SEC STAFF
33sz7i
4 Feb 21
SEC staff action: Order
12:00am